Urgent: an updated sexual health policy maltatoday.com.mt - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from maltatoday.com.mt Daily Mail and Mail on Sunday newspapers.
Zenabis receives Malta license for medical cannabis production
Zenabis Global’s Maltese joint venture ZenPharm obtains Maltese licence to produce cannabis for medicinal and research purposes,
15 May 2021, 12:52pm
by Matthew Vella
ZenPharm is the second licencee to be given the go-ahead to a medical cannabis licence in Malta
Zenabis Global’s Maltese joint venture ZenPharm has received its Maltese licence to produce cannabis for medicinal and research purposes, after a two-year process by the Malta Medicines Authority.
The receipt of the Medicinal Cannabis License follows on the earlier European Union Good Manufacturing Practices certification issued by Malta Medicines Authority in January 2021.
A leading Canadian cannabis producer will be shipping some 500kg of the plant out of Malta ever year after it was given the go-ahead to start operating by local authorities.
Zenabis Global announced on Friday that its Maltese joint venture, ZenPharm Limited, has received its medicinal cannabis license from the Maltese regulatory authorities.
It plans to start shipping around half a ton of cannabis out of Malta annually, with its medicinal cannabis license allowing ZenPharm to commence commercial shipments to the EU, where Germany is ZenPharm s most prominent target market.
The company, which will operate from Ħal Far Industrial Estate, will not be growing cannabis locally. Instead, it will import cannabis from its Canadian partner Zenabis, process it locally and then export it to the EU and UK.
Materia Announces Receipt of EU-GMP Certification in Malta
Materia Malta or the
EU GMP ) certification from the Malta Medicines Authority.
EU GMP is the global gold standard for pharmaceutical production and a requirement for medical cannabis in most European jurisdictions. This certification will enable Materia to begin processing and exporting medical cannabis flower from Malta into end markets across Europe, following the final post-certification steps in accordance with the licensure process. The Company also intends to apply for a licence amendment to process cannabis extracts imminently, leveraging the comprehensive preparatory work already completed. Becoming EU GMP certified in Malta represents our most significant milestone since we embarked on this project over two years ago, said Deepak Anand, CEO of Materia. We are excited to turn the engine on and showcase the full potential of a Malta-based cannabis processor to the industry, especially global partners seeking
The health authorities are looking into whether a thrombosis case in Malta is linked in any way to COVID vaccination.
In a statement late on Wednesday, the Health Ministry said it has been informed of a 58-year-old person who suffered thrombosis two weeks after receiving the first dose.
The ministry did not specify the brand of the administered vaccine.
RELATED STORIES
The person is in a stable condition, it reassured, adding that the Malta Medicines Authority is looking into the matter.
Earlier this month the European Medicines Authority said blood clots were a very rare side effect of the AstraZeneca jab and the benefits outweighed the risks.